In this case, the patient had no family history of genetic disorders, and germline genetic testing ruled out pathogenic variants in Lynch syndrome-related genes (MLH1, MSH2, MSH6, PMS2) and other cancer susceptibility genes (APC, BRCA1/2, TP53), indicating a sporadic etiology. This evidence concerns the gene TP53 and Lynch syndrome.